| Literature DB >> 27293547 |
Alyssa J Rolfe1, Dale B Bosco1, Jingying Wang1, Richard S Nowakowski1, Jianqing Fan2, Yi Ren1.
Abstract
BACKGROUND: The single-stranded RNA Flavivirus, Zika virus (ZIKV), has recently re-emerged and spread rapidly across the western hemisphere's equatorial countries, primarily through Aedes mosquito transmission. While symptoms in adult infections appear to be self-limiting and mild, severe birth defects, such as microcephaly, have been linked to infection during early pregnancy. Recently, Tang et al. (Cell Stem Cell 2016, doi: 10.1016/j.stem.2016.02.016) demonstrated that ZIKV efficiently infects induced pluripotent stem cell (iPSC) derived human neural progenitor cells (hNPCs), resulting in cell cycle abnormalities and apoptosis. Consequently, hNPCs are a suggested ZIKV target.Entities:
Year: 2016 PMID: 27293547 PMCID: PMC4902960 DOI: 10.1186/s13578-016-0110-x
Source DB: PubMed Journal: Cell Biosci ISSN: 2045-3701 Impact factor: 7.133
Top 30 genes up-regulated in ZIKV infected hNPCs compared to controls
| Gene symbol | Entrez | Gene name | Log2 FC | p value |
|---|---|---|---|---|
| IFIT2 | 3433 | Interferon-induced protein with tetratricopeptide repeats 2 | 5.22967 | 0.0051 |
| TNFRSF14 | 8764 | Tumor necrosis factor receptor superfamily, member 14 | 3.4467 | 0.00005 |
| BHLHE41 | 79365 | Basic helix-loop-helix family, member e41 | 3.41193 | 0.00005 |
| SNORD116-4 | 100033416 | Small nucleolar RNA, C/D box 116-4 | 3.3541 | 0.00065 |
| CEBPB | 1051 | CCAAT/enhancer binding protein (C/EBP), beta | 3.08608 | 0.00005 |
| SEC24D | 9871 | SEC24 family, member D ( | 3.06648 | 0.00005 |
| CHAC1 | 79094 | ChaC, cation transport regulator homolog 1 ( | 2.98802 | 0.00005 |
| CREB3L1 | 90993 | cAMP responsive element binding protein 3-like 1 | 2.9718 | 0.00005 |
| DDIT3 | 1649 | DNA-damage-inducible transcript 3 | 2.94172 | 0.00005 |
| STC2 | 8614 | Stanniocalcin 2 | 2.85446 | 0.00005 |
| IL20RB | 53833 | Interleukin 20 receptor beta | 2.74302 | 0.00005 |
| ADM2 | 79924 | Adrenomedullin 2 | 2.73791 | 0.00005 |
| DDR2 | 4921 | Discoidin domain receptor tyrosine kinase 2 | 2.68283 | 0.00005 |
| ULBP1 | 80329 | UL16 binding protein 1 | 2.6589 | 0.00005 |
| SLC7A11 | 23657 | Solute carrier family 7 (anionic amino acid transporter light chain, xc-system), member 11 | 2.55855 | 0.00005 |
| GABRR2 | 2570 | Gamma-aminobutyric acid (GABA) A receptor, rho 2 | 2.54697 | 0.00025 |
| FOSL1 | 8061 | FOS-like antigen 1 | 2.54626 | 0.00005 |
| RELB | 5971 | v-rel reticuloendotheliosis viral oncogene homolog B | 2.52167 | 0.00005 |
| BHLHE40 | 8553 | Basic helix-loop-helix family, member e40 | 2.50278 | 0.00005 |
| INHBE | 83729 | Inhibin, beta E | 2.48416 | 0.00005 |
| XBP1 | 7494 | X-box binding protein 1 | 2.48392 | 0.00005 |
| SELPLG | 6404 | Selectin P ligand | 2.47628 | 0.00005 |
| SLC7A5 | 8140 | Solute carrier family 7 (amino acid transporter light chain, L system), member 5 | 2.44283 | 0.00005 |
| ARHGAP9 | 64333 | Rho GTPase activating protein 9 | 2.42899 | 0.00005 |
| HERPUD1 | 9709 | Homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 | 2.38525 | 0.00005 |
| KLF15 | 28999 | Kruppel-like factor 15 | 2.36633 | 0.00005 |
| CDC42EP1 | 11135 | CDC42 effector protein (Rho GTPase binding) 1 | 2.35073 | 0.00005 |
| CEBPD | 1052 | CCAAT/enhancer binding protein (C/EBP), delta | 2.34979 | 0.00025 |
| GAL3ST2 | 64090 | Galactose-3- | 2.31589 | 0.0021 |
| FAM129A | 116496 | Family with sequence similarity 129, member A | 2.28808 | 0.00005 |
Top 30 genes down-regulated in ZIKV infected hNPCs compared to controls
| Gene symbol | Entrez | Gene name | Log2 FC | p-value |
|---|---|---|---|---|
| SIGLEC10 | 89790 | Sialic acid binding Ig-like lectin 10 | −3.60664 | 0.00005 |
| CDC20B | 166979 | Cell division cycle 20 homolog B ( | −3.44083 | 0.0002 |
| OR51E2 | 81285 | Olfactory receptor, family 51, subfamily E, member 2 | −3.05742 | 0.0001 |
| CCNO | 10309 | Cyclin O | −3.00562 | 0.00005 |
| SLCO4A1 | 28231 | Solute carrier organic anion transporter family, member 4A1 | −2.97508 | 0.0229 |
| SGPP2 | 130367 | Sphingosine-1-phosphate phosphatase 2 | −2.69025 | 0.00035 |
| RRM2 | 6241 | Ribonucleotide reductase M2 | −2.63783 | 0.00005 |
| SFXN2 | 118980 | Sideroflexin 2 | −2.61672 | 0.00005 |
| COLEC12 | 81035 | Collectin sub-family member 12 | −2.60458 | 0.00005 |
| CHRNA1 | 1134 | Cholinergic receptor, nicotinic, alpha 1 (muscle) | −2.5688 | 0.00005 |
| PRR22 | 163154 | Proline rich 22 | −2.54683 | 0.00045 |
| DHFR | 1719 | Dihydrofolate reductase | −2.53145 | 0.00005 |
| MFI2 | 4241 | Antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5 | −2.50748 | 0.00005 |
| MAPK15 | 225689 | Mitogen-activated protein kinase 15 | −2.46203 | 0.00005 |
| C21orf58 | 54058 | Chromosome 21 open reading frame 58 | −2.39697 | 0.00005 |
| SPEF1 | 25876 | Sperm flagellar 1 | −2.39565 | 0.00005 |
| GHRL | 51738 | Ghrelin/obestatin prepropeptide | −2.35804 | 0.00805 |
| ATG16L2 | 89849 | Autophagy related 16-like 2 ( | −2.34225 | 0.00005 |
| CXCL14 | 9547 | Chemokine (C-X-C motif) ligand 14 | −2.33189 | 0.0015 |
| SUSD2 | 56241 | Sushi domain containing 2 | −2.28898 | 0.00005 |
| C6orf118 | 168090 | Chromosome 6 open reading frame 118 | −2.27987 | 0.00005 |
| DLX6-AS1 | 285987 | DLX6 antisense RNA 1 | −2.26662 | 0.00005 |
| ADAM28 | 10863 | ADAM metallopeptidase domain 28 | −2.25906 | 0.00005 |
| NXPH2 | 11249 | Neurexophilin 2 | −2.22856 | 0.00005 |
| AQP7P1 | 375719 | Aquaporin 7 pseudogene 1 | −2.2255 | 0.00005 |
| EFCAB1 | 79645 | EF-hand calcium binding domain 1 | −2.19918 | 0.00005 |
| WNT8B | 7479 | Wingless-type MMTV integration site family, member 8B | −2.19366 | 0.00005 |
| PI15 | 51050 | Peptidase inhibitor 15 | −2.17615 | 0.00005 |
| C1orf189 | 388701 | Chromosome 1 open reading frame 189 | −2.17531 | 0.01255 |
| OLFML3 | 56944 | Olfactomedin-like 3 | −2.16835 | 0.0016 |
Fig. 1Comprehensive gene set gene ontology analysis. Gene ontology analysis was performed on hNPC genes whose expression was significantly altered following infection with ZIKV for 56 h. Transcript enrichment significance was determined using the human protein coding genome as the reference background. a Regulation of nucleic acid metabolism was the only biological process sub-ontology enriched with ZIKV up-regulated genes. Down-regulated genes were enriched for pathways related to cell cycle regulation and general metabolism. All significant terms are presented. b Cellular component enrichment indicated down-regulated genes generally associated with chromosomal regions, the extracellular matrix, and centrosomes. Up-regulated genes showed the most enrichment for the Golgi apparatus. Both up- and down-regulated genes were significantly enriched in nuclear sites. Enrichment scores were sorted by the most significant terms, and the top 11 compartments are represented. (q < 0.05)
Fig. 2ZIKV DEGs mapped to canonical human disease gene sets. Using the MalaCards database of human diseases, diseases with established clinical significance to ZIKV infection were queried. ZIKV DEGs were then compared to reference gene list for each disease to determine a percentage of representation. Diseases related to congenital CNS disorders were most highly represented with ZIKV DEGs. Although less, representation of adult inflammatory and demyelinating diseases were also observed. (Bars % of ZIKV induced genes present in the reference list) (Open circles total number of genes in the disease reference list)
Neurological clinical phenotypes associated with ZIKV DEGs
| Disease | Gene symbol | Gene name |
|---|---|---|
| Microcephaly | DYRK1A | Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A |
| MCPH1 | Microcephalin 1 | |
| CASK | Calcium/calmodulin-dependent serine protein kinase (MAGUK family) | |
| PHGDH | Phosphoglycerate dehydrogenase | |
| ARFGEF2 | ADP-ribosylation factor guanine nucleotide-exchange factor 2 | |
| ASPM | Asp (abnormal spindle) homolog, microcephaly associated | |
| CENPJ | Centromere protein J | |
| CEP152 | Centrosomal protein 152 kDa | |
| SLC25A19 | Solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19 | |
| WDR62 | WD repeat domain 62 | |
| CDK5RAP2 | CDK5 regulatory subunit associated protein 2 | |
| CASC5 | Cancer susceptibility candidate 5 | |
| NBN | Nibrin | |
| EFTUD2 | Elongation factor Tu GTP binding domain containing 2 | |
| IER3IP1 | Immediate early response 3 interacting protein 1 | |
| STIL | SCL/TAL1 interrupting locus | |
| CEP135 | Centrosomal protein 135 kDa | |
| ZNF335 | Zinc finger protein 335 | |
| NDE1 | nudE nuclear distribution E homolog 1 | |
| DIAPH1 | Diaphanous homolog 1 | |
| KIF11 | Kinesin family member 11 | |
| Congenital nervous system disorders | MCPH1 | Microcephalin 1 |
| ARFGEF2 | ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited) | |
| TGIF1 | TGFB-induced factor homeobox 1 | |
| GRIN2B | Glutamate receptor, ionotropic, | |
| SLC12A5 | Solute carrier family 12 (potassium/chloride transporter), member 5 | |
| FLNA | Filamin A, alpha | |
| SIX3 | SIX homeobox 3 | |
| SHH | Sonic hedgehog | |
| CDK5RAP2 | CDK5 regulatory subunit associated protein 2 | |
| NDE1 | nudE nuclear distribution E homolog 1 | |
| WDR62 | WD repeat domain 62 | |
| ASPM | Asp (abnormal spindle) homolog, microcephaly associated | |
| CENPJ | Centromere protein J | |
| STIL | SCL/TAL1 interrupting locus | |
| FKTN | Fukutin | |
| POMGNT1 | Protein O−linked mannose beta1,2−N−acetylglucosaminyltransferase | |
| CEP152 | Centrosomal protein 152 kDa | |
| POMT2 | Protein−O−mannosyltransferase 2 | |
| GLI2 | GLI family zinc finger 2 | |
| ZNF335 | Zinc finger protein 335 | |
| Epilepsy syndrome | CDKL5 | Cyclin−dependent kinase−like 5 |
| CSTB | Cystatin B (stefin B) | |
| TSC1 | Tuberous sclerosis 1 | |
| CACNB4 | Calcium channel, voltage−dependent, beta 4 subunit | |
| CLCN2 | Chloride channel, voltage−sensitive 2 | |
| PCDH19 | Protocadherin 19 | |
| KCNQ2 | Potassium voltage−gated channel, KQT−like subfamily, member 2 | |
| CLN5 | Ceroid−lipofuscinosis, neuronal 5 | |
| ATP1A2 | ATPase, Na +/K + transporting, alpha 2 polypeptide | |
| LGI1 | Leucine−rich, glioma inactivated 1 | |
| SCN1B | Sodium channel, voltage−gated, type I, beta subunit | |
| ALDH5A1 | Aldehyde dehydrogenase 5 family, member A1 | |
| EFHC1 | EF−hand domain (C−terminal) containing 1 | |
| Encephalitis | DDX58 | DEAD (Asp−Glu−Ala−Asp) box polypeptide 58 |
| RPSA | Ribosomal protein SA | |
| TREX1 | Three prime repair exonuclease 1 | |
| Demyelinating disease | PLP1 | Proteolipid protein 1 |
| RTN4 | Reticulon 4 | |
| GALC | Galactosylceramidase | |
| GBS | FAS | Fas (TNF receptor superfamily, member 6) |
Fig. 3Gene ontology functional network of biological process and immune system terms. All significantly altered genes greater than 0.5 fold-change were imported into Cytoscape and Gene Ontology clustering was performed with the ClueGO plugin. The human genome was used as the background with the GO biological process and immune system terms queried for enrichment. Terms were generated such that GO Term Fusion was implemented on pathways with a less than 0.01 q-value. Groupings with less than 3 connections were excluded from the final list of networks. Terms related to cytokine and chemokine production as well as general pathogen response formed networks independent of nucleic acid and macromolecule metabolic processes
Fig. 4Divergent gene expression patterns in CMV and ZIKV-infected hNPCs. Genes significantly different between mock and cells infected with either CMV or ZIKV were processed identically and resulting significant biological pathways were mapped. Clustering was performed on the resulting pathways such that similar functions were grouped for clarity. The Cytokine/Chemokine and Pathogen Response clusters were enlarged to demonstrate the divergent pathway enrichment between ZIKV and CMV infection
Fig. 5Immune specific biological pathways enriched in up-regulated genes. a The biological pathways associated with ZIKV transcript changes were filtered to include top immune specific pathways. b Using a FDR q-value <0.05, several top immune function pathways were enriched for the up-regulated gene set, although none of the pathways were enriched for significant down-regulated transcripts. The q-values for the pathway enrichment are annotated along the left panel as the dot plot. c Using tissue specific expression databases, up- and down-regulated genes were probed for immune related cells and tissues. Innate and adaptive immune system components were represented in both lists. (q < 0.05)
Fig. 6Activation of NF-κB and STATs signaling pathway in ZIKV-infected hNPCs. Cytokines (IL-1 and TNF-α), PAMPs, CD40 and CXCL12 interact with their receptors resulting in activation of the NF-κB pathway. IFN-γ, IL-6 and IL-12 binding to their receptors induces STAT dimerization and translocation to the nucleus. Activation of both the canonical NF-κB and STAT signaling pathways, results in the production of numerous inflammatory cytokines.